Humankind Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Sell |
1,191
-239
| -17% | -$125K | 0.15% | 72 |
|
|
2025
Q1 | $907K | Buy |
1,430
+132
| +10% | +$83.7K | 0.24% | 59 |
|
|
2024
Q4 | $925K | Buy |
1,298
+498
| +62% | +$355K | 0.23% | 57 |
|
|
2024
Q3 | $841K | Sell |
800
-113
| -12% | -$119K | 0.3% | 54 |
|
|
2024
Q2 | $960K | Sell |
913
-61
| -6% | -$64.1K | 0.25% | 55 |
|
|
2024
Q1 | $937K | Sell |
974
-90
| -8% | -$86.6K | 0.25% | 53 |
|
|
2023
Q4 | $935K | Sell |
1,064
-4
| -0.4% | -$3.51K | 0.28% | 51 |
|
|
2023
Q3 | $879K | Sell |
1,068
-72
| -6% | -$59.3K | 0.37% | 40 |
|
|
2023
Q2 | $819K | Buy |
1,140
+250
| +28% | +$180K | 0.32% | 45 |
|
|
2023
Q1 | $731K | Sell |
890
-15
| -2% | -$12.3K | 0.3% | 53 |
|
|
2022
Q4 | $653K | Sell |
905
-164
| -15% | -$118K | 0.28% | 58 |
|
|
2022
Q3 | $736K | Buy |
1,069
+225
| +27% | +$155K | 0.35% | 43 |
|
|
2022
Q2 | $499K | Buy |
844
+145
| +21% | +$85.7K | 0.24% | 62 |
|
|
2022
Q1 | $488K | Buy |
699
+59
| +9% | +$41.2K | 0.2% | 66 |
|
|
2021
Q4 | $404K | Buy |
640
+76
| +13% | +$48K | 0.51% | 63 |
|
|
2021
Q3 | $341K | Sell |
564
-12
| -2% | -$7.26K | 0.52% | 63 |
|
|
2021
Q2 | $322K | Buy |
+576
| New | +$322K | 0.57% | 55 |
|